Introduction
Trichomoniasis, caused by the protozoan parasite Trichomonas vaginalis, is one of the most common curable STDs. It is estimated that there are over 3.7 million people with trichomoniasis in the United States and 1.1 million new cases each year. In women, infection with T. vaginalis has been suggested to be associated with adverse pregnancy outcomes, including premature rupture of membranes and pre-term labor, pelvic inflammatory disease, and increased risk for HIV infection. Based on the estimated incident cases among all ages in 2008, the total lifetime direct medical cost of trichomoniasis in the US was estimated at $24.0 million [1] [2] . In the US, Trichomonas vaginalis (TV) infections are not reportable to state agencies and therefore actual prevalence data is limited. In addition, as many as 85% of infected women 1 are asymptomatic and therefore do not even undergo testing. Also, in those that are tested, the sensitivity of diagnostic tests varies widely. Trichomonasvaginalis is a flagellated protozoan that causes trichomoniasis in human. Studies have shown that Trichomonasvaginalis is one of the most prevalent sexually transmitted pathogens in the world, it has been estimated by WHO that about 170 million cases occurs every year [1] . The epidemiology of the disease is still not well understood and some medical personnel continue to doubt its importance. However, there is growing evidence that T vaginalis is an important pathogen, both in its own right due to the "immediate" morbidity associated with infection, [2] for its role in the promotion of premature rupture of membranes, premature labor, and low birth weight, [3] [4] and because of the likelihood of predisposing of HIV transmission [5] [6] [7] . While a slightly increased risk for HIV transmission may have minor significance for an individual, it may be of considerable importance at a community level [8] . Understanding the relation between T vaginalis and other sexually transmitted infections would assist its use as a marker for the success of behavioral and treatment interventions targeting other STDs including HIV [9] . Few studies examine the prevalence of TV across age groups, and many are limited by the diagnostic tests previously described. A recent study (5) used real-time PCR assays and compared by age groups the rates of T. vaginalis, C. trachomatis and N. gonorrhea in Florida, Texas and New Jersey [8] [9] [10] [11] .
Materials and Methods
This cohort study was carried out 100 female patients attending the General Hospital Nasarawa, Nasarawa state,
Nigeria. An informed consent was obtained from all respondents and demographic information such as age, education and occupationwere recorded in the questionnaires. High vaginal swab samples were collected by inserting a sterile speculum into the posterior fornix of the vagina while the individual is in the lithotomic position. The natures of the collected samples were noted such as the colour, consistency and odour; the samples were then put in 0.3 mL of sterile physiological saline. The resulting suspension was put on a clean slide, covered with a cover slip and examined immediately under the microscope. A smear of the secretion was also made on a slide, air dried and fixed in absolute methanol for 1 min. Diluted Giemsa stain was poured on the smear and allowed to stain for 10 min after which it was washed, air dried and examined under the microscope. Chisquared (χ 2 ) test was used to compare T. vaginalis infection relative to clinical manifestations and parasitological results. Analyses were performed with SPSS (version 18; SPSS Inc, Chicago, IL, USA), with a probability (P) value of <0.05 were considered as statistically significant. 
Result

Discussion
The absence of prospective data in well defined populations means that the true dynamics of T vaginalis infection are unknown. Nevertheless, the most striking feature of the epidemiology is the consistently high prevalence found in women in developing and disadvantaged populations.
The effects of T vaginalis on pregnancy outcome have been known for many years [9] and are now receiving increased attention [4] . It is possible that treatment of women with T vaginalis in pregnancy will reduce the incidence of premature rupture of membranes and premature labour [14] , although one study has failed to show this [10] . Of course, lowering the risk of infection in the first place through reductions in the community prevalence of the disease is a
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Attending the General Hospital Nasarawa, Nasarawa State better long term option. Trichomoniasis is the most common non-viral sexual infection that causes infection in genitourinary tract [14] [15] . Infection is mainly transmitted through sexual activity, although non-sexual transmission is also reported [12] . Almost 2%-17% of female infants may be infected by their mothers [13] . In the United States, the prevalence of trichomoniasis has been estimated at 25% in those referred to STDs clinics and it is higher in certain population groups such as African American women (38%) [2] . Contrary to some studies which have reported a 25% or higher infection rate in Africa [2] , this study has recorded a lower prevalence of 12%. Although, the prevalence of trichomoniasis in HIVpositive women in Zaire and pregnant women in a rural area in South Africa is estimated to be as high as 38% and 65%, respectively [11] [12] . In Islamic countries, the prevalence of trichomoniasis ranges from 1.2% in Libya and Jordan, 3.2% in Turkey to 28.1% in Saudi Arabia [16] [17] [18] [19] .
Studies from Africa have suggested that T. vaginalis infection may increase the rate of HIV transmission by approximately twofold [10] . Detection and treatment of trichomoniasis may be important strategies in reducing HIV transmission through sexually transmitted infection control. Recommendations for single dose nitroimidazole therapy for all women who have been sexually active at any stage in their life may be appropriate and could be instituted at family planning clinics and other primary healthcare facilities in areas of known high endemic prevalence [10] [11] Studies conducted in Brazil have shown that the prevalence of T. vaginalis infection ranges from 2.6% [20] to 20% in women evaluated in primary care centers of different regions of the country [21] [22] [23] [24] , those living with HIV [25] [26] [27] , and pregnant women [28] . To improve the infection control, and especially to determine risk factors, some aspects of the approaches should be studied [15] . Thus, given the lack of available data for T. vaginalis infection in Southern Brazil, the present study aimed to identify the risk factors associated with infection, and to investigate the prevalence of the parasite in women of different municipalities in the middle of the southwest region of Rio Grande do Sul State, RS, Brazil [28] .
Infection with T vaginalis has been largely ignored by most health professionals since its discovery over 160 years ago but its relative importance is now beginning to be recognized. Control of the disease is dependent on a cheap, safe, and well tolerated antibiotic and should not be ignored.
Conclusion
In conclusion, the results of this study shows the prevalence of T. vaginalis infection in the study population is relatively low and other causes of vaginitis such as bacterial and fungal infections should be given more consideration. Since clinical signs of trichomonal vaginitis are the same of other STDs, a confirmatory laboratory diagnosis is necessary. Further studies in different population groups are needed to determine other aspects of epidemiology of this infection in Iran.
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